Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Pleural Effusion, Malignant|Breast Cancer
Interventions: DRUG: Bevacizumab
Sponsor: Institut Curie
Collaborators: Henri Mondor University Hospital